Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Kopran Ltd

KOPRAN.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$1.99

▲ +5.00%

Market Cap $96.23M · Vol 147.07K

Key Metrics

P/E Ratio

36.58

FWD: N/A

Market Cap

$96.23M

Micro Cap

Div Yield

1.58%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

41.65

Momentum

Beta

1.47

vs Market

52W High

$2.29

13.55% below

52W Low

$1.12

75.73% above

Volume

147.07K

Avg 133.28K

P/B

0.98

Price-to-book

ROE

N/A

Return on equity

Free Float

49.79%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Kopran Ltd (KOPRAN.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does KOPRAN.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.96%

-8.24%

+20.43%

+41.77%

YTD

+26.44%

+21.17%

-0.72%

-10.98%

Financials & Valuation

TTM · Annual

Total Revenue	$72.91M
Net Income	$2.75M
Revenue Growth (YoY)	+13.89%
Gross Margin	27.59%
Operating Margin	8.87%
Net Profit Margin	3.78%
ROE	N/A
ROA · ROIC	3.92% · 4.80%

P/E Ratio	36.58
Forward P/E (FY1)	N/A
PEG Ratio	-0.61
P/S	0.76
P/B	0.98
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	48.29M

Technical Indicators

50-Day SMA	$2.00
200-Day SMA	$1.64
RSI (14)	41.65
Beta	1.47
52-Week High	$2.29
52-Week Low	$1.12

Volume Today	147.07K
Avg Daily Volume (30D)	133.28K
Relative Volume	1.10x
Volatility (10D)	50.60
Volatility (30D)	41.77
Free Float	49.79%

Analyst Consensus

N/A

Current Price $1.99

Mean Target N/A

52W Low$1.12 52W High$2.29

Current

Target

$1.12 $2.29

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S83WG8

ISININE082A01010

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.